Investor Resources Home

Webcast ImageWebcast - Replay
Heron Therapeutics Inc at Leerink Partners 5th Annual Global Healthcare Conference
02/10/16 at 1:25 p.m. ET
At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents. Our goal is to build on therapeutics with well-known pharmacology by improving their safety and efficacy as well as broadening their potential field of use.
HRTX (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$18.48
Change (%) Stock is Down 0.28 (1.49%)
Volume715,571
Data as of 02/10/16 4:00 p.m. ET
Refresh quote

Corporate Presentation

DateTitle
02/08/16
Download Documentation Corporate Presentation February 8, 2016

Recent News

More >>
DateTitle 
02/04/16Heron Therapeutics to Present at the Leerink Partners 5th Annual Global Healthcare ConferencePrinter Friendly Version
01/28/16Heron Therapeutics Appoints Kimberly J. Manhard as Executive Vice President of Drug DevelopmentPrinter Friendly Version
01/15/16Heron Therapeutics Notified by FDA That It Will Not Take Action on SUSTOL® New Drug Application by the PDUFA DatePrinter Friendly Version
11/10/15Heron Therapeutics to Participate in Investor Conferences in November 2015Printer Friendly Version

Upcoming Events

More >>

There are currently no events scheduled.

Data provided by NASDAQ. Minimum 15 minutes delayed.